IDEAS home Printed from https://ideas.repec.org/a/spr/patien/v4y2011i2p133-141.html
   My bibliography  Save this article

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients

Author

Listed:
  • Michael Iskedjian
  • David Covert
  • John Walker

Abstract

Background: Glaucoma is one of the leading causes of blindness and visual disability. Few studies have examined persistence and adherence with topical medications in glaucoma patients. Objective: The objective of this study was to compare patient persistence with prostaglandin agonist (PA) monotherapy versus with concomitant adjunctive therapy (AT) in Canada. Methods: Data were obtained from the Québec prescription claims database. Persistence rates were determined for previously treated naive glaucoma patients at 1 year after their index date for use of any of the three available PAs (bimatoprost, latanoprost, and travoprost). Patients who had at least 334 days on their index PA were defined as being persistent during the analysis timeframe. Patient baseline demographics and persistence rates were reported. A logistic regression was used for comparing the PA and PA + AT groups, which incorporated baseline cofounders, such as age and sex, in the analyses. Results: From an initial cohort of 28 534 patients, 14 893 were identified as naive to glaucoma therapy and had a PA as their index therapy. Of these, 11 197 (75.2%) continued to receive monotherapy and 3696 (24.8%) had an AT added to the PA; 59.0% were females, and the average age was 70.5 ± 11.3 years. Overall, at the end of the first year of therapy, 57.4% of patients were persistent on their index PA; however, a statistically significant difference was observed between the two subgroups, with 54.6% for those receiving PA monotherapy and 65.8% for those receiving PA + AT (p > 0.01) persistent with therapy. On average, 10.5 prescriptions per year were dispensed to persistent patients. Conclusions: In this Canadian population, persistence rates fall to approximately 60% at the end of the first year of therapy, with patients taking AT being more persistent. Similar persistence analyses are warranted on other populations, and would yield helpful data for conducting economic evaluations of non-persistence. Copyright Adis Data Information BV 2011

Suggested Citation

  • Michael Iskedjian & David Covert & John Walker, 2011. "Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 4(2), pages 133-141, June.
    • Handle: RePEc:spr:patien:v:4:y:2011:i:2:p:133-141
    DOI: 10.2165/11539460-000000000-00000
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/11539460-000000000-00000
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.2165/11539460-000000000-00000?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Gurwitz, J.H. & Glynn, R.J. & Monane, M. & Everitt, D.E. & Gilden, D. & Smith, N. & Avorn, J., 1993. "Treatment for glaucoma: Adherence by the elderly," American Journal of Public Health, American Public Health Association, vol. 83(5), pages 711-716.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yunjeong Jang & Donghyun Jee & Donghwan Lee & Nam-Kyong Choi & SeungJin Bae, 2021. "Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data," IJERPH, MDPI, vol. 18(8), pages 1-12, April.
    2. Stefanie Frech & Daniel Kreft & Rudolf F Guthoff & Gabriele Doblhammer, 2018. "Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—An observational cohort study," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-14, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:patien:v:4:y:2011:i:2:p:133-141. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.